全文获取类型
收费全文 | 49388篇 |
免费 | 3519篇 |
国内免费 | 1356篇 |
专业分类
耳鼻咽喉 | 397篇 |
儿科学 | 1656篇 |
妇产科学 | 1677篇 |
基础医学 | 5062篇 |
口腔科学 | 1256篇 |
临床医学 | 7878篇 |
内科学 | 5710篇 |
皮肤病学 | 596篇 |
神经病学 | 2166篇 |
特种医学 | 2360篇 |
外国民族医学 | 20篇 |
外科学 | 3529篇 |
综合类 | 10752篇 |
现状与发展 | 11篇 |
一般理论 | 2篇 |
预防医学 | 3057篇 |
眼科学 | 999篇 |
药学 | 2315篇 |
80篇 | |
中国医学 | 1323篇 |
肿瘤学 | 3417篇 |
出版年
2024年 | 33篇 |
2023年 | 607篇 |
2022年 | 1034篇 |
2021年 | 1730篇 |
2020年 | 2014篇 |
2019年 | 1446篇 |
2018年 | 1421篇 |
2017年 | 1473篇 |
2016年 | 1837篇 |
2015年 | 1627篇 |
2014年 | 3116篇 |
2013年 | 3236篇 |
2012年 | 2863篇 |
2011年 | 3066篇 |
2010年 | 2491篇 |
2009年 | 2420篇 |
2008年 | 2372篇 |
2007年 | 2651篇 |
2006年 | 2472篇 |
2005年 | 2165篇 |
2004年 | 1929篇 |
2003年 | 1689篇 |
2002年 | 1384篇 |
2001年 | 1278篇 |
2000年 | 961篇 |
1999年 | 803篇 |
1998年 | 623篇 |
1997年 | 615篇 |
1996年 | 568篇 |
1995年 | 545篇 |
1994年 | 492篇 |
1993年 | 446篇 |
1992年 | 355篇 |
1991年 | 333篇 |
1990年 | 299篇 |
1989年 | 239篇 |
1988年 | 279篇 |
1987年 | 227篇 |
1986年 | 183篇 |
1985年 | 186篇 |
1984年 | 121篇 |
1983年 | 80篇 |
1982年 | 102篇 |
1981年 | 89篇 |
1980年 | 86篇 |
1979年 | 76篇 |
1978年 | 60篇 |
1977年 | 27篇 |
1976年 | 34篇 |
1975年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Tau Ming Liew 《Journal of the American Medical Directors Association》2019,20(8):1054.e11-1054.e20
ObjectivesEarly diagnosis of cognitive impairment is increasingly emphasized in the literature to facilitate timely preventive interventions. Although bedside cognitive tests such as the Montreal Cognitive Assessment (MoCA) are widely used for such early diagnostic purposes, they may not have comparable performance to a full neuropsychological battery (FNB) in diagnosing early cognitive impairment. This study investigated whether a small subset of neuropsychological tests can be added on to MoCA to match its performance to that of the FNB in discriminating mild cognitive impairment and dementia (MCI/dementia) from normal cognition.DesignCross-sectional diagnostic study.SettingAlzheimer's Disease Centers across the United States.ParticipantsOlder participants (≥50 years) who completed MoCA and the FNB (N = 9187).MeasuresThe study sample was split into two: the derivation sample (n = 1837) was used to develop a brief neuropsychological battery that best discriminated MCI/dementia (using the best-subset approach with 10-fold cross-validation); while the validation sample (n = 7350) verified its actual performance in discriminating MCI/dementia.ResultsA 3-item neuropsychological battery was identified, comprising MoCA, Benson Complex Figure Recall, and Craft Story 21 Delayed Recall. It had excellent performance in discriminating MCI/dementia from normal cognition (area under the receiver operating characteristic curve [AUROC] 90.0%, 95% confidence interval [CI] 89.2%-90.7%), which was comparable to that of the FNB (AUROC 88.4%, 95% CI 87.6%-89.2%). By contrast, MoCA alone had significantly worse AUROC (86.9%, 95% CI 86.0%-87.7%) than that of the FNB.Conclusions/ImplicationsUsing rigorous methods, this study developed a brief neuropsychological battery that maintained the brevity of a bedside cognitive test, while rivaling the diagnostic performance of an FNB in early cognitive impairment. This brief battery offers a viable alternative when the FNB is needed but cannot be feasibly administered in nonspecialty clinics. It can have a wider health systems effect of improving patients’ access to accurate diagnosis in early cognitive impairment and facilitating timely interventions to delay the progression of cognitive impairment. 相似文献
92.
Henrieke W. Schutte MD Guido B. van den Broek MD PhD Stefan C. A. Steens MD PhD Rosella P. M. G. Hermens PhD Jimmie Honings MD PhD Henri A. M. Marres MD PhD Matthias A. W. Merkx MD PhD Willem L. J. Weijs MD Anne I. J. Arens MD Adriana C. H. van Engen–van Grunsven MD PhD Carla M. L. van Herpen MD PhD Johannes H. A. M. Kaanders MD PhD Frank J. A. van den Hoogen MD PhD Robert P. Takes MD PhD 《Cancer》2020,126(17):3982-3990
93.
目的分析2018—2019年河北省城市癌症早诊早治项目结直肠癌筛查结果。方法按照河北省城市癌症早诊早治中结直肠癌筛查流程,在石家庄市和唐山市选定社区中年龄40~74岁的当地居民,通过问卷调查后采用国家统一评估模型评估出高危人群,进一步通过结肠镜检查,发现早期结直肠病变,必要时通过病理进行确诊。结果 2018—2019年度,河北省城癌项目共计37849人完成结直肠癌危险因素问卷调查,评估结直肠癌高危人群6938例,总体高危率为18.33%。其中共有1230人参加了结肠镜检查,并完成病理检查465例(37.80%)。进行病理诊断者年龄主要分布在50~64岁。经结肠镜检查及病理诊断,共检出6例(0.49%)结直肠癌患者,其中结肠癌4例(0.33%)、直肠癌2例(0.16%)。结直肠癌癌前病变190例(15.45%),非进展期腺瘤/息肉250例(20.33%),炎性反应性肠道疾病168例(13.66%)。结论开展人群结肠镜筛查可以有效检出结直肠癌和癌前病变,实现结直肠癌的早期发现、早期诊断和早期干预。 相似文献
94.
95.
目的探讨目标教学在前列腺超声诊断技术带教中的应用效果。方法选择2017年1月-2018年12月于我院进行前列腺超声诊断技术培训的影像学专业学生80例,根据入院时间先后顺序分为研究组与对照组,每组40例。对照组医学生采用常规教学法带教,研究组医学生采用目标教学法带教,比较两组带教效果。结果研究组医学生的超声诊断仪使用(94.12±2.73)分、超声扫查技巧(92.81±5.06)分、操作技能(90.83±5.11)分、超声图像表现掌握(91.96±3.67)分均高于对照组(P<0.05)。研究组医学生的总体满意度CEQ评分(8.22±0.24)分高于对照组的(5.25±0.30)分,两组比较差异具有统计学意义(P<0.05)。结论目标教学在前列腺超声诊断技术带教中的应用效果良好,可有效提高医学生的操作能力,提高医学生对带教模式的肯定度。 相似文献
96.
新型冠状病毒肺炎(简称新冠肺炎)归属中医"疫病",主要病位在肺,主要病机为"湿、毒",治疗上解毒化湿贯穿始终。新冠肺炎的主要诊断方法为核酸检测,《新型冠状病毒肺炎诊疗方案(试行第七版)》新增加了血清学检测。中医药在新冠肺炎的预防方面具有很大优势,如中医预防方、香囊、针灸、中国传统功法、食疗、足浴、熏蒸等。在新冠肺炎的治疗过程中,中西医结合疗法效果明显,在缓解患者早期临床症状,减少患者轻症向重症、重症向危重症转化的发生率方面具有重要价值。目前尚无治疗新冠肺炎的特效药,对新冠肺炎的认识尚不完整,因此,文章从新冠肺炎的诊断、预防和治疗3个角度出发,探讨了对新冠肺炎中西医方面的认识,为进一步明确新冠肺炎的诊疗提供参考。 相似文献
97.
98.
《Clinical Lymphoma, Myeloma & Leukemia》2020,20(6):e270-e283
BackgroundB-cell chronic lymphoproliferative disorders (B-CLPDs) are characterized by the sustained accumulation of monoclonal B cells. Limited studies have systematically described the clinical features and outcomes of the whole patient group, especially in Eastern populations.Patients and MethodsA total of 1592 patients with newly diagnosed B-CLPD were enrolled. Chronic lymphocytic leukemia (CLL) accounted for 39%, and Waldenström macroglobulinemia (WM), leukemic marginal zone lymphoma, follicular lymphoma (FL), and mantle cell lymphoma (MCL) constituted 13%, 13%, 9%, and 8% of cases, respectively.ResultsThe median age at diagnosis was 58 years, and the male/female ratio was 1.8:1. The 17p and 11q deletions were most common in MCL (36% and 17%, respectively), and 13q deletion and trisomy 12 were most frequent in CLL (35% and 21%, respectively). Patients with leukemic MCL had significantly worse survival than that of patients with other disease entities, with a 3-year overall survival (OS) of 58%, followed by 68.2% for WM/lymphoplasmacytic lymphoma. Those with CLL, leukemic marginal zone lymphoma, and FL had relatively favorable outcomes, with a 5-year OS > 80%. The survival of patients with B-CLPDs has improved over time with the emergence of novel drugs (3-year OS improvement from 82.1% to 92.2%). The improvement in survival mainly resulted from improvement among patients with MCL, WM/lymphoplasmacytic lymphoma, and FL. On multivariate analysis, only hemoglobin, lactate dehydrogenase, and 17p deletion were independently associated with survival (hazard ratio, 1.6, 2.0, and 3.1, respectively).ConclusionsComprehensive analysis of the clinical characteristics, immunophenotypic profiles, and cytogenetic features can be helpful in the differential diagnosis, especially for patients without a non–bone marrow biopsy specimen available. Universal prognostic factors could help with the early detection of high-risk patients and stratification for risk-adapted therapy. 相似文献
99.
100.